EMDB/PDB/SASBDBから引用されている文献のデータベース

キーワード
構造解析手法	All X線回折 NMR 電子顕微鏡小角散乱中性子線回折線維回折粉末回折赤外分光 EPR FRET 理論モデルハイブリッド
著者・登録者
ジャーナル
IF	>30 >20 >10 >5 all

タイトル	Crystal Structure of the CHK1
ジャーナル・号・ページ	To be Published
掲載日	2012年6月27日 (構造データの登録日)
著者	Kang, Y.N. / Stuckey, J.A. / Chang, P. / Russell, A.J.
リンク	PubMedで検索
手法	X線回折
解像度	1.9 - 2.5 Å
構造データ	PDB-4fsm: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 2.3 Å PDB-4fsn: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 2.1 Å PDB-4fsq: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 2.4 Å PDB-4fsr: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 2.5 Å PDB-4fst: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 1.9 Å PDB-4fsu: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 2.1 Å PDB-4fsw: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 2.3 Å PDB-4fsy: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 2.3 Å PDB-4fsz: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 2.3 Å PDB-4ft0: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 2.3 Å PDB-4ft3: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 2.5 Å PDB-4ft5: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 2.4 Å PDB-4ft7: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 2.2 Å PDB-4ft9: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 2.2 Å PDB-4fta: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 2.4 Å PDB-4ftc: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 2 Å PDB-4fti: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 2.2 Å PDB-4ftj: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 2.2 Å PDB-4ftk: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 2.3 Å PDB-4ftl: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 2.5 Å PDB-4ftm: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 1.9 Å PDB-4ftn: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 2.02 Å PDB-4fto: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 2.1 Å PDB-4ftq: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 2 Å PDB-4ftr: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 2.25 Å PDB-4ftt: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 2.3 Å PDB-4ftu: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 2.1 Å PDB-4gh2: Crystal Structure of the CHK1 手法: X-RAY DIFFRACTION / 解像度: 2.03 Å
化合物	ChemComp-HK1: 4-(6,7-dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenol ChemComp-SO4: SULFATE ION / 硫酸ジアニオン ChemComp-GOL: GLYCEROL / グリセロ-ル ChemComp-IPA: ISOPROPYL ALCOHOL / 2-プロパノ-ル / alkaloidYM ChemComp-HOH: WATER ChemComp-A58: 4-(6-{[(4-METHYLCYCLOHEXYL)AMINO]METHYL}-1,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)BENZOIC ACID ChemComp-HK3: 4'-(6,7-dimethoxyindeno[1,2-c]pyrazol-3-yl)biphenyl-4-ol ChemComp-HKC: 6,7-dimethoxy-3-[4-(1H-tetrazol-5-yl)phenyl]-1,4-dihydroindeno[1,2-c]pyrazole ChemComp-HK4: 4-[(6,7-dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)ethynyl]-2-methoxyphenol ChemComp-HK5: 4-[6-(1H-imidazol-1-ylmethyl)-7-methoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl]benzonitrile ChemComp-HK6: 8-chloro-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one / 8-クロロ-5,10-ジヒドロ-11H-ジベンゾ[b,e][1,4]ジアゼピン-11-オン ChemComp-HK7: 2-(11-oxo-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepin-3-yl)benzamide ChemComp-HK8: (3-chloro-11-oxo-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepin-8-yl)acetic acid ChemComp-HK9: 2-methoxy-4-(11-oxo-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepin-3-yl)benzoic acid ChemComp-H1K: 1-(5-chloro-2,4-dimethoxyphenyl)-3-pyrazin-2-ylurea ChemComp-H2K: 1-{5-chloro-2-[(3R)-pyrrolidin-3-yloxy]phenyl}-3-(5-cyanopyrazin-2-yl)urea ChemComp-H3K: 1-{5-bromo-2-[(3R)-3-hydroxypiperidin-1-yl]phenyl}-3-(5-cyanopyrazin-2-yl)urea ChemComp-H4K: 1-(5-cyanopyrazin-2-yl)-3-isoquinolin-3-ylurea ChemComp-H5K: 6-{[(5-cyanopyrazin-2-yl)carbamoyl]amino}naphthalene-2-carboxylic acid ChemComp-H6K: 1-(5-cyanopyrazin-2-yl)-3-(5-phenyl-1H-pyrazol-3-yl)urea ChemComp-H7K: methyl 5-(6-{[(cis-4-hydroxycyclohexyl)amino]methyl}-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)furan-2-carboxylate ChemComp-H8K: trans-4-({[3-(furan-3-yl)-2,4-dihydroindeno[1,2-c]pyrazol-6-yl]methyl}amino)cyclohexanol ChemComp-H9K: 3-(4'-hydroxybiphenyl-4-yl)-2,4-dihydroindeno[1,2-c]pyrazol-6-ol ChemComp-H0K: 4'-[7-(hydroxymethyl)-2,4-dihydroindeno[1,2-c]pyrazol-3-yl]biphenyl-4-ol ChemComp-1HK: 4-[2-(2,4-dihydroindeno[1,2-c]pyrazol-3-yl)ethyl]-2-methoxyphenol ChemComp-2HK: 4'-{6-methoxy-7-[2-(piperidin-1-yl)ethoxy]-1,2-dihydroindeno[1,2-c]pyrazol-3-yl}biphenyl-4-ol ChemComp-3HK: 4-{7-methoxy-6-[3-(morpholin-4-yl)propoxy]-1,4-dihydroindeno[1,2-c]pyrazol-3-yl}benzonitrile ChemComp-4HK: 5-{7-ethyl-6-[(3S)-tetrahydrofuran-3-yloxy]-2,4-dihydroindeno[1,2-c]pyrazol-3-yl}pyridine-2-carbonitrile ChemComp-5HK: 2-[3-(3-methoxy-4-nitrophenyl)-11-oxo-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepin-8-yl]-N,N-dimethylacetamide ChemComp-6HK: methyl [3-(1-methyl-1H-imidazol-5-yl)-11-oxo-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepin-8-yl]acetate ChemComp-7HK: methyl [11-oxo-3-(pyridin-4-ylamino)-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepin-8-yl]acetate ChemComp-HK0*: 3-(3-methoxy-4-nitrophenyl)-6-[2-(morpholin-4-yl)ethoxy]-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one
由来	homo sapiens (ヒト)
キーワード	TRANSFERASE/TRANSFERASE inhibitor / TRANSFERASE / TRANSFERASE-TRANSFERASE inhibitor complex